Takuya Masui
Impact in
-
- Tryptophan and brain disorders
- Psychiatry and Mental health top 10%
- Bipolar Disorder and Treatment
- Schizophrenia research and treatment
Papers in
-
- Bipolar Disorder and Treatment 6
- Electroconvulsive Therapy Studies 4
- Schizophrenia research and treatment 3
- Epilepsy research and treatment 2
-
- Neurotransmitter Receptor Influence on Behavior 5
- Co-authors
- Tsukasa Koyama (15 shared papers)Ichiro Kusumi (10 shared papers)Teruaki Tanaka (6 shared papers)Shin Nakagawa (6 shared papers)Katsuji Suzuki (6 shared papers)Takeshi Inoue (6 shared papers)Ryota Hashimoto (3 shared papers)Makoto Daiguji (1 shared paper)
- Journals
- Progress in Neuro-Psychopharmacology and Biological Psychiatry (6 papers)Journal of Psychiatry and Neuroscience (1 paper)Psychiatry and Clinical Neurosciences (1 paper)Therapeutic Drug Monitoring (1 paper)Journal of Affective Disorders (1 paper)
- Partner nations
- Japan
In The Last Decade
Takuya Masui
16 papers receiving 248 citations
Peers
Comparison fields: 5 of 56
- Biological Psychiatry 28
- Psychiatry and Mental health 96
- Behavioral Neuroscience 12
- Cellular and Molecular Neuroscience 62
- Pharmacology 32
Countries citing papers authored by Takuya Masui
This map shows the geographic impact of Takuya Masui's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Takuya Masui with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Takuya Masui more than expected).
Fields of papers citing papers by Takuya Masui
This network shows the impact of papers produced by Takuya Masui. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Takuya Masui. The network helps show where Takuya Masui may publish in the future.
Co-authors
The 25 scholars most cited alongside Takuya Masui, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2006 | 68 | |
| 2 | 2005 | 44 | |
| 3 | 2010 | 29 | |
| 4 | 2006 | 28 | |
| 5 | 2007 | 21 | |
| 6 | 2005 | 13 | |
| 7 | 2007 | 8 | |
| 8 | 2008 | 8 | |
| 9 | 2006 | 8 | |
| 10 | 2006 | 7 | |
| 11 | 2007 | 6 | |
| 12 | 2008 | 5 | |
| 13 | 2005 | 4 | |
| 14 | 2007 | 3 | |
| 15 | [Clinical relevance of antidepressant-induced activation syndrome: from a perspective of bipolar spectrum disorder]. | 2007 | 3 |
| 16 | [Perospirone therapy in elderly patients with schizophrenia]. | 2003 | 2 |
About Takuya Masui
Takuya Masui is a scholar working on Psychiatry and Mental health, Cellular and Molecular Neuroscience, Pharmacology, Biological Psychiatry and Speech and Hearing, having authored 16 papers that have together received 257 indexed citations. Recurring topics across this work include Bipolar Disorder and Treatment (6 papers), Neurotransmitter Receptor Influence on Behavior (5 papers), Electroconvulsive Therapy Studies (4 papers), Schizophrenia research and treatment (3 papers), Treatment of Major Depression (3 papers), Adolescent and Pediatric Healthcare (2 papers), Epilepsy research and treatment (2 papers) and Tryptophan and brain disorders (2 papers). The work is most often cited by research in Biological Psychiatry (28 citations), Psychiatry and Mental health (96 citations), Behavioral Neuroscience (12 citations), Cellular and Molecular Neuroscience (62 citations) and Pharmacology (32 citations). Takuya Masui has collaborated with scholars based in Japan. Frequent co-authors include Tsukasa Koyama, Ichiro Kusumi, Teruaki Tanaka, Shin Nakagawa, Katsuji Suzuki, Takeshi Inoue, Ryota Hashimoto, Makoto Daiguji, Yasuyuki Nomura and Masayuki Kaneko. Their work appears in journals such as Progress in Neuro-Psychopharmacology and Biological Psychiatry, Journal of Psychiatry and Neuroscience, Psychiatry and Clinical Neurosciences, Therapeutic Drug Monitoring and Journal of Affective Disorders.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.